(Q37949514)

25 August 2017

title

Current challenges in the clinical management of hypertension (English)

1 reference

25 August 2017

main subject

arterial hypertension

0 references

Luis M Ruilope

1

0 references

language of work or name

English

0 references

publication date

25 October 2011

1 reference

Nature Reviews Cardiology

25 August 2017

published in

1 reference

25 August 2017

volume

9

1 reference

25 August 2017

issue

5

1 reference

25 August 2017

page(s)

267-275

1 reference

Global burden of blood-pressure-related disease, 2001.

25 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.157

Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.157

2007 Guidelines for the Management of Arterial Hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.157

Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.157

Blood pressure, stroke, and coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.157

Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.157

Rationale and design of the Dietary Approaches to Stop Hypertension trial (DASH). A multicenter controlled-feeding study of dietary patterns to lower blood pressure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.157

A clinical trial of the effects of dietary patterns on blood pressure. DASH Collaborative Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.157

The effect of Mediterranean diet on metabolic syndrome and its components: a meta-analysis of 50 studies and 534,906 individuals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.157

Mediterranean diet, traditional risk factors, and the rate of cardiovascular complications after myocardial infarction: final report of the Lyon Diet Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.157

Salt reduction lowers cardiovascular risk: meta-analysis of outcome trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.157

British Hypertension Society guidelines for hypertension management 2004 (BHS-IV): summary

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.157

Impact of high-normal blood pressure on the risk of cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.157

Feasibility of treating prehypertension with an angiotensin-receptor blocker

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.157

The PHARAO study: prevention of hypertension with the angiotensin-converting enzyme inhibitor ramipril in patients with high-normal blood pressure: a prospective, randomized, controlled prevention trial of the German Hypertension League

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.157

Antihypertensive treatment and secondary prevention of cardiovascular disease events among persons without hypertension: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.157

Resolved and unresolved issues in the prevention and treatment of coronary artery disease: a workshop consensus statement

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.157

The cardiovascular disease continuum validated: clinical evidence of improved patient outcomes: part I: Pathophysiology and clinical trial evidence (risk factors through stable coronary artery disease).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.157

The cardiovascular disease continuum validated: clinical evidence of improved patient outcomes: part II: Clinical trial evidence (acute coronary syndromes through renal disease) and future directions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.157

Preventing microalbuminuria in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.157

Preventing left ventricular hypertrophy by ACE inhibition in hypertensive patients with type 2 diabetes: a prespecified analysis of the Bergamo Nephrologic Diabetes Complications Trial (BENEDICT).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.157

Risk prediction is improved by adding markers of subclinical organ damage to SCORE.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.157

Changes in albuminuria predict mortality and morbidity in patients with vascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.157

Effects of telmisartan, ramipril, and their combination on left ventricular hypertrophy in individuals at high vascular risk in the Ongoing Telmisartan Alone and in Combination With Ramipril Global End Point Trial and the Telmisartan Randomized Asse

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.157

Renal function and target organ damage in hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.157

Facts and fallacies of blood pressure control in recent trials: implications in the management of patients with hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.157

The effects of blood pressure reduction and of different blood pressure-lowering regimens on major cardiovascular events according to baseline blood pressure: meta-analysis of randomized trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.157

Prognostic value of long-term blood pressure variability: the evidence is growing

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.157

The relationship between visit-to-visit variability in systolic blood pressure and all-cause mortality in the general population: findings from NHANES III, 1988 to 1994.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.157

Effects of antihypertensive-drug class on interindividual variation in blood pressure and risk of stroke: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.157

Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.157

Management of essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.157

Prognostic value of blood pressure in patients with high vascular risk in the Ongoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.157

Tight blood pressure control and cardiovascular outcomes among hypertensive patients with diabetes and coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.157

Effects of intensive blood-pressure control in type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.157

Intensive Blood-Pressure Control in Hypertensive Chronic Kidney Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.157

Lowering blood pressure reduces renal events in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.157

Telmisartan to prevent recurrent stroke and cardiovascular events

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.157

Compliance, safety, and effectiveness of fixed-dose combinations of antihypertensive agents: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.157

Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.157

Renal outcomes with different fixed-dose combination therapies in patients with hypertension at high risk for cardiovascular events (ACCOMPLISH): a prespecified secondary analysis of a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.157

The importance of prompt blood pressure control

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.157

Olmesartan medoxomil/amlodipine/hydrochlorothiazide: fixed-dose combination in hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.157

Antihypertensive efficacy of hydrochlorothiazide as evaluated by ambulatory blood pressure monitoring: a meta-analysis of randomized trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.157

The role of chlorthalidone in patients with high-risk hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.157

Chlorthalidone reduces cardiovascular events compared with hydrochlorothiazide: a retrospective cohort analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.157

Treatment of hypertension in patients 80 years of age or older

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.157

Antihypertensive drugs in very old people: a subgroup meta-analysis of randomised controlled trials. INDANA Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.157

Orthostatic hypotension in older adults. The Cardiovascular Health Study. CHS Collaborative Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.157

Reevaluating the use of antihypertensive medications, a first step toward reducing polypharmacy in very old patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.157

Resistant hypertension: diagnosis, evaluation, and treatment. A scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.157

Prevalence of resistant hypertension in the United States, 2003-2008.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.157

Efficacy of spironolactone therapy in patients with true resistant hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.157

Aldosteronism and resistant hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.157

Narrative review: the emerging clinical implications of the role of aldosterone in the metabolic syndrome and resistant hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.157

Hyperaldosteronism and left ventricular hypertrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.157

Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.157

Effect of renal sympathetic denervation on glucose metabolism in patients with resistant hypertension: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.157

Long-term follow-up after tight control of blood pressure in type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.157

Role of home blood pressure monitoring in overcoming therapeutic inertia and improving hypertension control: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.157

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.157

Adherence to antihypertensive medications and cardiovascular morbidity among newly diagnosed hypertensive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.157

Effects of dietary sodium reduction on blood pressure in subjects with resistant hypertension: results from a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.157

Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.157

Novel therapeutic targets for hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.157

Blood-pressure reduction with LCZ696, a novel dual-acting inhibitor of the angiotensin II receptor and neprilysin: a randomised, double-blind, placebo-controlled, active comparator study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.157

Assessment of frequency of progression to hypertension in non-hypertensive participants in the Framingham Heart Study: a cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.157

Olmesartan for the Delay or Prevention of Microalbuminuria in Type 2 Diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.157

Effects of intensive blood pressure reduction on myocardial infarction and stroke in diabetes: a meta-analysis in 73 913 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.157

Antihypertensive therapy for prehypertension: relationship with cardiovascular outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.157

Regression of electrocardiographic left ventricular hypertrophy during antihypertensive therapy and reduction in sudden cardiac death: the LIFE Study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.157

A lifetime of prevention: the case of heart failure

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.157

Discrepancies between Office and Ambulatory Blood Pressure: Clinical Implications

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.157

Prognostic significance of visit-to-visit variability, maximum systolic blood pressure, and episodic hypertension

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.157

When should antihypertensive drug treatment be initiated and to what levels should systolic blood pressure be lowered? A critical reappraisal

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.157

The clock is ticking: the case for achieving more rapid control of hypertension

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.157

Orthostatic hypertension: the last hemodynamic frontier

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.157

Clinical Features of 8295 Patients With Resistant Hypertension Classified on the Basis of Ambulatory Blood Pressure Monitoring

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.157

Effects of chronic baroreceptor stimulation on the autonomic cardiovascular regulation in patients with drug-resistant arterial hypertension

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.157

How common is true resistant hypertension?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.157

Effects of the angiotensin receptor blocker azilsartan medoxomil versus olmesartan and valsartan on ambulatory and clinic blood pressure in patients with stages 1 and 2 hypertension

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.157

Reduction in albuminuria translates to reduction in cardiovascular events in hypertensive patients with left ventricular hypertrophy and diabetes.

31 March 2020

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22027655

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Rapid reversal of left ventricular hypertrophy and intracardiac volume overload in patients with resistant hypertension and hyperaldosteronism: a prospective clinical study

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22027655

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1038/NRCARDIO.2011.157

1 reference

25 August 2017

1 reference